← back to search

Thorsten R. Mempel

Harvard University · US
Area of research
Immunology · Oncology
Research interest
Research interests include Immune Cell Function and Interaction, T-cell and B-cell Immunology, Immunotherapy and Immune Responses, and Cancer Immunotherapy and Biomarkers.
h-index
56
citations
18,666
works
136
NIH funding
primary concept
Medicine
email

Recent publications

Interruption of the intratumor CD8+ T cell:Treg crosstalk improves the efficacy of PD-1 immunotherapy
Cancer Cell 2024cited by 92position: middledoi
<i>CXCL9:SPP1</i> macrophage polarity identifies a network of cellular programs that control human cancers
Science 2023cited by 584position: middledoi
Dendritic cells as shepherds of T cell immunity in cancer
Immunity 2023cited by 250position: lastdoi
CXCR6 positions cytotoxic T cells to receive critical survival signals in the tumor microenvironment
Cell 2021cited by 458position: lastdoi
T cells armed with C-X-C chemokine receptor type 6 enhance adoptive cell therapy for pancreatic tumours
Nature Biomedical Engineering 2021cited by 172position: middledoi
The Extracellular RNA Communication Consortium: Establishing Foundational Knowledge and Technologies for Extracellular RNA Research
Cell 2019cited by 225position: middledoi
Targeting the CBM complex causes Treg cells to prime tumours for immune checkpoint therapy
Nature 2019cited by 207position: lastdoi
Multidimensional communication in the microenvirons of glioblastoma
Nature Reviews Neurology 2018cited by 564position: middledoi
Bone degradation machinery of osteoclasts: An HIV-1 target that contributes to bone loss
Proceedings of the National Academy of Sciences 2018cited by 74position: middledoi
Tumor Tolerance–Promoting Function of Regulatory T Cells Is Optimized by CD28, but Strictly Dependent on Calcineurin
The Journal of Immunology 2018cited by 23position: lastdoi
SCS macrophages suppress melanoma by restricting tumor-derived vesicle–B cell interactions
Science 2016cited by 343position: middledoi
Proceedings of the Frontiers of Retrovirology Conference 2016
Retrovirology 2016cited by 37position: middledoi
The Transcription Factor NFAT Promotes Exhaustion of Activated CD8 + T Cells
Immunity 2015cited by 837position: middledoi
Visualization and tracking of tumour extracellular vesicle delivery and RNA translation using multiplexed reporters
Nature Communications 2015cited by 588position: middledoi
Directly visualized glioblastoma-derived extracellular vesicles transfer RNA to microglia/macrophages in the brain
Neuro-Oncology 2015cited by 315position: middledoi
Consensus nomenclature for CD8<sup>+</sup>T cell phenotypes in cancer
OncoImmunology 2015cited by 136position: middledoi
Dynamic Treg interactions with intratumoral APCs promote local CTL dysfunction
Journal of Clinical Investigation 2014cited by 235position: lastdoi
CXCR3 Chemokine Receptor-Ligand Interactions in the Lymph Node Optimize CD4+ T Helper 1 Cell Differentiation
Immunity 2012cited by 427position: middledoi
HIV-infected T cells are migratory vehicles for viral dissemination
Nature 2012cited by 321position: lastdoi

Grants

No grants ingested yet.

Frequent collaborators

Francesco Marangoni · UC Irvine Health7 papers (2012–2024)Esteban Carrizosa · Massachusetts General Hospital4 papers (2014–2021)Xandra O. Breakefield · Harvard University4 papers (2015–2018)Edward Y. Kim · University of California, Berkeley4 papers (2014–2019)Ross D. Warner · Massachusetts General Hospital3 papers (2018–2021)Charles Pin‐Kuang Lai · University of California System3 papers (2015–2016)Andrew D. Luster · Harvard University3 papers (2012–2021)Mauro Di Pilato · The University of Texas MD Anderson Cancer Center3 papers (2019–2023)Mikäel J. Pittet · University of Geneva3 papers (2016–2023)Ulrich H. von Andrian · Harvard University3 papers (2012–2016)Bruno L. Cadilha · University Hospital Regensburg2 papers (2019–2021)Thomas T. Murooka · University of Manitoba2 papers (2012–2012)Ralph Weissleder · Harvard University2 papers (2015–2016)V. Mani · Indian Institute of Science Bangalore2 papers (2018–2019)Anna M. Krichevsky · Brigham and Women's Hospital2 papers (2015–2018)Christopher Garris · Harvard University2 papers (2016–2023)Erik R. Abels · Medisch Centrum Haaglanden2 papers (2015–2018)Tarmo Äijö · Massachusetts Institute of Technology2 papers (2015–2018)Gustavo Martínez · Yale Cancer Center2 papers (2015–2018)Valentina Zappulli · University of Padua2 papers (2018–2019)